Research

Call for Proposals: Bowel & Cancer Research

Thursday, 14 September 2017 08:51

Bowel & Cancer Research is seeking high quality applications for consideration at its funding round in March 2018.

Our area of interest is lower GI/ bowel research in malignant and non-malignant, diagnostic or treatment studies or device/intervention development for which future translation to tangible patient benefit can be anticipated. Areas of interest include, but are not limited to:

  • Colorectal cancer
  • Inflammatory Bowel Disease (colitis and Crohn's disease)
  • IBS
  • Stoma prevention/improvement in quality of life

Funding is available for research projects specifically addressing Chronic Intestinal Pseudo Obstruction/Dysmotility leading to intestinal failure via our partners at the Pseudo Obstruction Research Trust (PORT).

Funding is available through the Lucy Thomas Fund for a research project specifically addressing the BRAF mutation in colorectal cancer, particularly in relation to poor patient prognosis.

Funding is available for a research project specifically addressing the impact of diet and nutritional therapy (excluding enteral and parental) on patients diagnosed with Ehlers Danlos Syndrome (EDS).

Awards of up to £50,000 are available for time limited (indicatively 12-18 months) proof-of-principle studies based on sound hypotheses with real future patient benefit.

Successful applicants will be expected to make a strong case for how Bowel & Cancer Research funding will be used to lever further funding to continue resulting work.

Full guidance and preliminary application forms can be downloaded from http://bit.ly/resapp18

This is a 2 stage process. The deadline for all preliminary applications is 5pm Friday 27th October 2017. Applicants will be notified in early December if a full application is invited and final decisions will be made in March 2018.

NIHR HTA 17/76 - Home-blended food for children with gastrostomy tubes

Friday, 25 August 2017 15:09

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. Full details are available from the NIHR website. Application deadline is 1pm on 30 November 2017.

NIHR HTA 17/83 - Biological response modifier drugs for rare autoimmune diseases

Friday, 25 August 2017 15:03

The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. Full details are available from the NIHR website. Application deadline 1pm on 30 November 2017.

Kenneth Rainin Foundation - Synergy Awards

Friday, 25 August 2017 14:52

The spirit of this award is to forge partnerships in the field of Inflammatory Bowel Disease, and collaboration is a key requirement of this award. It is essential to demonstrate that the end product of the proposed research could not be achieved without collaboration. Deadline for applications is Monday, 2nd October 2017. Award period starts 1st January 2018 and ends 31st December 2018. Go to http://krfoundation.org/health/grants/synergy-award/ for further information.

Bowel and Cancer Research Small Grants Funding

Friday, 25 August 2017 14:48

Funding is provided for time-limited research projects that in general will aim to provide proof-of-principle preliminary data such that the applicants can use the findings to apply subsequently for more substantive 3-5 year funding from a national public funder. The maximum amount awarded is £50,000 and maximum duration of project should be 18 months. They are particularly interested in seed-funding new work within the areas of bowel cancer, IBD, IBS, functional problems and stoma avoidance. The next call is due to open in September 2017.

Colorectal Therapies HTC (Healthcare Technology Collaborative) - Funding

Friday, 25 August 2017 14:42

The Colorectal Therapies HTC has a strong focus on supporting the development and translation of technology that will address the needs of patients affected by colorectal disease (includes colorectal cancers, IBD, IBS, Crohn’s Disease and Colitis). Their focus is on the following clinical unmet needs identified by clinicians and patients:

  • Prevention and early detection of anastomotic leak
  • Enhanced post-operative recovery
  • Prevention of complications of stoma
  • Early detection of disease
  • Prevention and treatment of post-operative ileus
  • Stratification of colorectal cancer
  • Prevention and repair of incisional hernia complications
  • Next generation surgical instruments (minimally invasive surgery
  • Early detection of sepsis and acute organ failure
  • Biosensors for incontinence detection
  • Improved prosthetic meshes for tissue reconstruction
  • Remote patient monitoring for early detection of post-operative complications
  • The Colorectal Therapies HTC can offer access to academics, engineers, and other multidisciplinary staff as well as access to patients, international collaborators and industry partners. If any individuals are interested in discussing potential collaborations, applications and/or research, then please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it on 0113 206 5256.

    MRC "Confidence in Concept" scheme

    Tuesday, 22 August 2017 15:19

    The Confidence in Concept scheme is a key part of MRC’s translational research strategy and provides annual awards of £250k-£1.2m to institutions, to be used flexibly to support the earliest stages of multiple translational research projects. It is intended to accelerate the transition from discovery science to the early stages of therapeutic/biomarker development projects by supporting preliminary work or feasibility studies to establish the viability of an approach. The projects supported should aim to provide sufficient preliminary data to establish the viability of an approach before seeking more substantive funding (e.g. from the Developmental Pathway Funding Scheme (DPFS).

    Details of the aims, the remit, eligibility, and how to apply are all available through the The Confidence in Concept scheme web page. Application deadline: 7 Nov 2017 16:00 GMT.

    NIHR HTA 17/87 - Proton pump inhibitor therapy for refractory gastro-oesophageal reflux symptoms

    Thursday, 03 August 2017 10:28

    The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. Full details are available from the NIHR website. Application dates: 03 August 2017 to 25 January 2018.

    NIHR HTA 17/72 - Treatment of steroid-resistant ulcerative colitis

    Thursday, 03 August 2017 10:23

    The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. Application dates: 03 August 2017 to 30 November 2017. Full details are included in the commissioning brief.

    NIHR RfPB Competition 34

    Thursday, 03 August 2017 10:13

    Applications are invited by the Research for Patient Benefit Programme for research proposals that are concerned with the day-to-day practice of health service staff, and which have the potential to have an impact on the health or wellbeing of patients and users of the NHS. As a response mode researcher-led programme, RfPB does not specify topics for research, but encourages proposals for projects which address a wide range of health service issues and challenges.

    The programme aims to fund high quality quantitative and qualitative research with a clear trajectory to patient benefit. It particularly encourages applications that have a strong element of interaction with patients and the public, and which have been conceived in association with a relevant group of service users. Full details are available on the NIHR website. Application dates: 02 August 2017 to 22 November 2017

    NIHR HTA 17/67 Primary antibiotic prophylaxis for spontaneous bacterial peritonitis in cirrhosis

    Thursday, 03 August 2017 10:08

    The Health Technology Assessment Programme is accepting stage 1 applications to their commissioned workstream for this primary research topic. Application dates: 03 August 2017 to 28 September 2017. Full details of the call are available on the NIHR website.

    Bowel Cancer UK Grant Round now open

    Wednesday, 02 August 2017 12:20

    Bowel Cancer UK have launched their first research funding round. In the next year, they will fund research of up to half a million pounds in the following priority areas:

    • Improving the bowel cancer screening programme and use of endoscopy resource so that more people are diagnosed at the earliest stage of the disease;
    • Increasing our understanding and improving the identification of people at high risk of bowel cancer, such as those with a strong family history or longstanding medical condition such as inflammatory bowel disease or type 2 diabetes;
    • Furthering our knowledge of bowel cancer in the under 50s to better understand why bowel cancer in this age group is growing and to help ensure patients are diagnosed as quickly as possible

    The project grant awards are aimed at supporting a piece of research for up to two years with a clearly defined subject area and outcomes. The grant will fund up to £75,000 per year, for up to two years, for any combination of salaries and consumables. You may also include budget for small items of essential equipment. All costs must be fully justified within the application.

    Grants are only made for projects where the Principal Applicant has a contract at a UK host institution that extends beyond the life of the grant. To request an application form and guidelines, or if you have any queries, please get in touch at This e-mail address is being protected from spambots. You need JavaScript enabled to view it , letting them know that you would like a project grant application. The deadline for return of applications is 4pm Thursday 21 September 2017.

     

    World Cancer Research Fund International

    Friday, 21 July 2017 15:42

    As part of its Regular Grant Programme 2017/2018 cycle, World Cancer Research Fund International (WCRF International) is now accepting grant applications for research on the links between diet, nutrition (including body composition), physical activity and cancer. WCRF International restructured the Grant Programme since the 2015/2016 cycle in order to focus on important knowledge gaps in the areas of cancer prevention and cancer survivors. Applicants can be based in any country outside the Americas. More information on the eligibility and the scientific scope of the grant call is available. Please ensure you read the ‘Guidelines for research grant applicants & award recipients’ carefully before applying. The deadline for applications is 6th October 2017.

    Grants for Collaborative Research Projects Related to IBD

    Tuesday, 06 June 2017 13:24

    The Kenneth Rainin Foundation will accept proposals for its Synergy Awards program from June 2 through October 2, 2017. The awards will fund teams of health researchers to pursue unconventional, collaborative projects that will advance the study of Inflammatory Bowel Disease (IBD).

    The grants support teams of up to three investigators for a maximum award of $100,000 per investigator, up to $300,000. View complete program information, eligibility requirements and application guidelines.

     

    Crohn’s and Colitis UK Research Awards 2018

    Friday, 26 May 2017 13:22

    Applications are invited for grants to be awarded in 2018 by Crohn's and Colitis UK. Research Projects may be directed towards:

    1. Medical - any aspect of Inflammatory Bowel Disease relevant to a better understanding of the causes or mechanisms of IBD or better treatment for IBD patients.
    2. Living with IBD - any aspect of the social and psychological impact of Inflammatory Bowel Disease including research into ways of helping patients and their families to live with IBD.
    3. Health Services - research with the potential to improve the services provided to the UK's IBD community and to drive up standards of care for patients with IBD.

    Funding for any one project is normally subject to a maximum of £120,000 over a period of up to three years. Applications for funding of pilot studies are also encouraged.

    Closing date for applications is 4pm on Friday, 22nd September 2017.

    An Application Form and Information for Applicants can be downloaded from www.crohnsandcolitis.org.uk or contact us at This e-mail address is being protected from spambots. You need JavaScript enabled to view it or on 01727 734 468.

    NIHR HTA 17/33 - Management of diarrhoea in patients with stable ulcerative colitis

    Friday, 31 March 2017 10:58

    The HTA is looking for applicants to address the research question "Which intervention strategy is most effective, and most acceptable to patients, in the treatment of diarrhoea associated with stable ulcerative colitis?" The treatment strategy would utilise pharmacological and/or dietary interventions to manage diarrhoea in adult patients with stable ulcerative colitis who have at least some evidence of disease activity and who have diarrhoea which affects their quality of life. Further details are in the commissioning brief and guidance notes. This call responds to the IBD PSP's top 10 research priorities 3 and 6. Additional information to support applicants is available from the funding and support listing for this call. The deadline for applications is 1pm, 28 September 2017.

    NIHR HTA 17/32 - Variceal bleeding in people with small oesophageal varices

    Friday, 31 March 2017 10:46

    The HTA is looking for applicants to answer the research questions "Do non-selective beta-blockers delay the onset or reduce the subsequent occurrence of variceal bleeding? Is their use cost effective?". This commissioned research call is based on BSG 2015 guidelines and NICE 2016 guidelines, both of which recognise that the current evidence for the use of nonsteroidal beta blockers as primary prevention is weak. Full details are in the commissioning brief and guidance notes. Additional information to support applicants is available from the funding and support listing. The deadline for applications is 1pm on 28 September 2017.

    €100,000 for future scientific research project: Application for UEG Research Prize 2017 is now open!

    Wednesday, 29 March 2017 12:42

    The annual Research Prize is awarded for excellence in basic science, translational or clinical research. UEG support a future scientific research project from early stage to successful conclusion. The recipient must be able to demonstrate that their previous work has had an impact in its field and its quality is recognised internationally.

    Application is open until May 12, 2017

    Kenneth Rainin Foundation Funding Calendar

    Friday, 25 November 2016 15:01

    The Rainin Foundation believes that providing early support for innovative ideas can lead to improvements in preventing, diagnosing and treating Inflammatory Bowel Disease. Find out more about the Foundation and view their grant awards calendar.

    HTA researcher-led funding opportunities

    Tuesday, 02 August 2016 09:01

    The researcher-led workstream welcomes proposals on topics or research questions identified by researchers within the programme’s remit. The HTA can verify this for you if you complete and submit a remit check form. The deadlines for the next rounds are Wednesday 9 August 2017 and Tuesday 5 December 2017. Details can be found on the HTA website.

    The Kenneth Rainin Foundation - Innovator Awards

    Tuesday, 26 July 2016 15:26

    The Kenneth Rainin Foundation supports research that is potentially transformative to diagnosing, treating and curing Inflammatory Bowel Disease. The Innovator Awards program provides $100,000 grants for one-year research projects, which due to their ground-breaking nature, may not be suitable for funding from more traditional sources. To date, they have funded projects in the following areas:

    • Bioengineering
    • Diet and Nutrition
    • Epithelial Cell/Molecular Biology
    • Fecal Microbiota Transplant
    • Immunity and Inflammation
    • Microbiome
    • Therapeutic Development and Delivery

    If you are submitting a clinical research proposal, they encourage you to include basic scientific methodologies to examine the underlying mechanisms of the proposed intervention/treatment.

    Funding criteria include:

    • Innovation
    • Scientific merit
    • Strong evidence of collaboration
    • Investigator capability to execute project

    Researchers from any scientific discipline at non-profit research institutions worldwide are eligible for funding. Typically, the researchers they fund hold advanced degrees (MD, PhD or the equivalent) and academic positions at universities, medical centers or research institutions. Innovator Awards may have only one principal investigator, and funding is awarded to their home institution; however, additional investigators may be listed as co-investigators.

    Letter of Inquiry Deadline: January 15 – February 15, annually

    Further Information

    The Haemochromatosis Society Grants

    Thursday, 21 July 2016 08:22

    The Society works with the scientific community to support research into genetic haemochromatosis, and provides grants to tackle basic scientific, treatment or social issues that affect patients with haemochromatosis.

    Grant proposals are accepted at any time from researchers working in recognised institutions in the UK. Suitable applications progress to peer-review and a decision as to whether to fund a project is made at the earliest possible quarterly board meeting.

    Projects that may improve the rates of diagnosis and lower the average age of diagnosis of genetic haemochromatosis are welcome.

    Scientific research into iron overload and its treatment is ongoing worldwide. The society has a small research budget, which the trustees apply after consulting our scientific advisers, to support research in the UK.

    Further Information

    The American Society of Colon and Rectal Surgeons (ASCRS) Limited Project Grant (LPG)

    Tuesday, 24 May 2016 10:24

    Purpose

    To provide the investigator with the opportunity to pursue research interests, specifically germane to the field of colon and rectal surgery. It is anticipated that successful research projects, initially funded through the Research Foundation’s LPG mechanism, will ultimately secure funding from other national funding agencies.

    Amount
    Up to 50,000USD/year
    Application Deadlines: March 1st and October 1st
    Review/Notification Date: Summer/Fall (March applicants) or Winter/Spring (October applicants)

    Further Information / Apply

    MRC Supporting new researchers towards independence

    Thursday, 28 April 2016 14:09

    To support early career researchers the MRC has increased the flexibility of its funding schemes available to post-doc researchers along with providing clearer guidance. Recognising that speed of progression can be affected by factors unrelated to an individual’s scientific potential, the MRC have removed time-bound eligibility criteria from New Investigator Research Grants.

    Further Guidance

    MRC Regenerative Medicine Research - New Funding Approach

    Thursday, 28 April 2016 13:56

    MRC has recently made some changes to the way regenerative medicine research is funded.

    The Regenerative Medicine Research Committee will now focus funding into Confidence in Concept projects, spreading its £2m allocation over ten or so projects.

    Further Guidance

    MRC Flexible Funding

    Thursday, 28 April 2016 13:31

    MRC fellowships are open to individuals returning to research following a career break.

    Applicants should make clear any substantive periods of absence from research within their application. Details of career breaks or flexible working will only be used to make appropriate adjustments when assessing an individual’s track record, productivity and career progression.

    Further Details

    NIHR Invention for Innovation Programme

    Tuesday, 12 April 2016 11:15

    Invention for Innovation (i4i) is a translational funding scheme to advance healthcare technologies and interventions for increased patient benefit in areas of existing or emerging clinical need. i4i supports collaborative research and development projects that have demonstrated proof-of-principle and have a clear pathway towards adoption and commercialisation. The expected output is an advanced or clinically validated prototype medical device, technology or intervention. The aim is to de-risk projects and make them attractive to follow-on funders and investors.

    There are two funding streams, Product Development awards and Challenge awards, which comprise early to late stage product development, including first-in-man and clinical feasibility studies and pivotal clinical studies to evaluate the safety and effectiveness for the intended use. The ultimate aim is to get products or services to a position where they can enter and be used within the NHS. Details of the application deadlines and more are available on the i41 site.

    National Cancer Research Institute (NCRI) Advisory Group

    Friday, 08 April 2016 15:25

    The NCRI Advisory Groups offer specialist advice and peer review for trial proposals or ideas in the areas of Molecular Biomarkers, Imaging, and Screening Prevention & Early Diagnosis (SPED). The Advisory Groups are 'open for business' and encourage you to get in touch with your trial ideas.

    Find out more here.

    Broad Medical Research Program at CCFA (BMRP-CCFA)

    Friday, 08 April 2016 13:03

    Crohn’s & Colitis Foundation of America recognises the importance of conducting innovative research that will lead to improvements in the prevention, diagnosis or therapy of Crohn’s disease or ulcerative colitis. CCFA funds innovative, clinically relevant research projects that will have the potential to impact the lives of patients with inflammatory bowel diseases. If you have an idea for an exploratory pilot research project, please consider applying for a grant from BMRP-CCFA. This is an investigator- friendly process with a three page Letter of Interest with a rolling deadline open to any nationality and rapid turnaround for decisions. BMRP-CCFA aims to help persons with inflammatory bowel diseases (IBD) by stimulating innovative, early stage research that opens new avenues for the diagnosis, therapy and prevention of these diseases. BMRP-CCFA is a great mechanism to fund innovative ideas that are clinically relevant and can lead to rapid change in the care of patients with inflammatory bowel diseases. Interested parties can find further information about the program and the projects it seeks to fund.

    NIHR Research Design Service

    Friday, 08 April 2016 12:58

    The NIHR Research Design Service (RDS) network helps researchers prepare proposals for submission to NIHR and other national, peer-reviewed funding competitions for applied health or social care research, by providing expert advice on research design and methodology. RDS advisers in bases across England offer a unique breadth of experience and a proven track record in improving research applications. Advice is confidential and free of charge. For more information, visit the Research Design Service website.

    The Crohn's in Childhood Research Association Bursaries

    Thursday, 07 April 2016 15:22

    Bursary grants of up to £400 (up to a total amount of £5,000pa) to enable UK based young doctors still in training/nurses/final year medical students and similar persons with an interest in the area of Crohn's and colitis (IBD) to support attendance at national, international scientific/educational congresses and if considered appropriate IBD related training courses. Also a £1000 annual bursary for travel/registration at national and international meetings for doctors in training to become paediatric gastroenterologists.

    Application forms and further information can be obtained from the CICRA website: http://www.cicra.org/what-we-do/research/grant-applications